Related Experiment Video
Updated: Jun 26, 2026
An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
miR-320 targets transferrin receptor 1 (CD71) and inhibits cell proliferation
Dale G Schaar1, Daniel J Medina, Dirk F Moore
1University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, The Cancer Institute of New Jersey, New Brunswick, NJ 08901, USA. schaardg@umdnj.edu
Objective:
MicroRNAs (miRNAs) have been implicated in complex vertebrate developmental systems, such as hematopoiesis, and may play an integral role in the development of human cancers. Based on these observations, we investigated the contribution of miRNAs to acute myelogenous leukemia cell lineage-specific differentiation.
Materials And Methods:
To facilitate the identification of miRNAs and their targets relevant to leukemic cell differentiation, changes miRNA expression were analyzed in the human leukemia cell line HL-60, which historically has been utilized to study lineage-specific changes in response to the differentiation agent 12-O-tetradecanoylphorbol-13-acetate (TPA).
Results:
Using this approach, we have identified a panel of TPA-induced miRNAs that are expressed coincident with HL-60 stereotypic morphological changes characteristic of monocytic differentiation. The transferrin receptor 1(TfR-1; CD71), whose surface expression is downregulated during TPA-mediated HL-60 cell differentiation, has been identified as a target of the TPA-induced miRNA miR-320. Cell culture experiments indicate that enforced miR-320 expression can suppress TfR-1 expression and cell proliferation.
Conclusion:
TPA induces the expression of several miRNAs in HL-60 cells, one such miRNA (miR-320) contributes to downregulation of TfR-1 surface expression characteristically seen during HL-60 monocytic differentiation. Moreover, TfR-1-targeting miRNAs, such as miR-320, may have potential as novel therapeutic agents for cancer due to their inhibitory effects on cell proliferation.
Insights
MicroRNAs (miRNAs) regulate cell differentiation in acute myelogenous leukemia. miR-320 targets transferrin receptor 1 (TfR-1), suppressing proliferation and potentially offering new cancer therapies.
Area of Science:
- Molecular Biology
- Cancer Research
- Developmental Biology
Background:
- MicroRNAs (miRNAs) are crucial in vertebrate development and cancer.
- Investigating miRNA roles in acute myelogenous leukemia (AML) cell differentiation is essential.
Purpose of the Study:
- To identify miRNAs and their targets involved in leukemic cell differentiation.
- To explore the function of specific miRNAs in HL-60 cell differentiation.
Main Methods:
- Analyzed miRNA expression changes in the HL-60 human leukemia cell line.
- Used 12-O-tetradecanoylphorbol-13-acetate (TPA) as a differentiation agent.
- Conducted cell culture experiments to assess miRNA effects on target gene expression and proliferation.
Main Results:
- Identified TPA-induced miRNAs correlating with HL-60 monocytic differentiation.
- Discovered miR-320 targets transferrin receptor 1 (TfR-1; CD71).
- Demonstrated that enforced miR-320 expression suppresses TfR-1 and cell proliferation.
Conclusions:
- TPA induces specific miRNAs, including miR-320, in HL-60 cells.
- miR-320 contributes to TfR-1 downregulation during monocytic differentiation.
- TfR-1-targeting miRNAs like miR-320 show therapeutic potential for cancer treatment.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:38Mitogens and the Cell Cycle